HCPCS Level II · Drugs administered other than oral method
J1562Injection, immune globulin (vivaglobin), 100 mg
Terminated 12/31/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1562
J1562 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, immune globulin (vivaglobin), 100 mg.
It was added to HCPCS effective 01/01/2007, and its current record took effect 01/01/2026.
It was terminated on 12/31/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Vivaglobin, inj
- Date added
- 01/01/2007
- Action effective
- 01/01/2026
- Termination date
- 12/31/2025
- BETOS
- O1E
Related J15xx codes
- J1551Injection, immune globulin (cutaquig), 100 mg
- J1552Injection, immune globulin (alyglo), 500 mg
- J1553Injection, immune globulin (yimmugo), 100 mg
- J1554Injection, immune globulin (asceniv), 500 mg
- J1555Injection, immune globulin (cuvitru), 100 mg
- J1556Injection, immune globulin (bivigam), 500 mg
- J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558Injection, immune globulin (xembify), 100 mg
- J1559Injection, immune globulin (hizentra), 100 mg
- J1560Injection, gamma globulin, intramuscular, over 10 cc
- J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
Common questions about J1562
Is HCPCS J1562 still valid?
- No. J1562 was terminated on 12/31/2025.
Does Medicare cover J1562?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.